Business Context and Reporting Period
Company: Texas Instruments Incorporated (TXN)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2026
Business Overview: TI designs and manufactures semiconductors, primarily Analog and Embedded Processing products, sold to electronics designers and manufacturers globally. The company operates two reportable segments: Analog and Embedded Processing, with a third category labeled "Other."
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Revenue | $4,825 | $4,069 |
| Gross Profit | $2,799 | $2,313 |
| Gross Margin | 58.0% | 56.8% |
| Operating Profit | $1,808 | $1,324 |
| Operating Margin | 37.5% | 32.5% |
| Net Income | $1,545 | $1,179 |
| Diluted EPS | $1.68 | $1.28 |
| Cash Flow from Operations | $1,520 | $849 |
| Free Cash Flow (Non-GAAP, TTM) | $4,351 | $1,715 |
| Total Debt (Carrying Value) | $14,050 | $14,048 |
| Cash & Short-Term Investments | $5,103 | $4,881 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 19% year-over-year (YoY) to $4.83 billion, driven by higher demand in the Analog segment (up 22%) and Embedded Processing segment (up 12%).
- Profitability Expansion: Operating profit rose 37% YoY to $1.81 billion. Gross margin improved to 58.0% from 56.8%, aided by higher revenue volume spreading fixed costs, partially offset by higher manufacturing costs from capacity expansions.
- Segment Performance:
- Analog: Operating profit surged 36% to $1.64 billion, with margins expanding to 41.7%.
- Embedded Processing: Operating profit jumped 205% to $122 million as the LFAB facility ramped up production, improving margins to 16.9%.
- Other: Revenue declined 16% and operating profit fell 38%, impacted by $17 million in acquisition charges related to the Silicon Labs deal.
- Cash Flow: Operating cash flow increased significantly to $1.52 billion (vs. $849 million YoY). Free cash flow for the trailing 12 months grew 154% to $4.35 billion.
- Capital Allocation: Capital expenditures decreased to $676 million (vs. $1.12 billion YoY) as the company nears the end of a six-year elevated capex cycle. Stock repurchases slowed to $158 million (vs. $653 million YoY).
Guidance, Outlook, and Risks
- Acquisition of Silicon Labs: TI announced a definitive agreement to acquire Silicon Labs for approximately $7.5 billion in an all-cash transaction, expected to close in the first half of 2027. The deal is funded by cash on hand and debt financing. $17 million in acquisition charges were incurred in Q1 2026.
- Capital Expenditure Outlook: Management expects to spend between $2 billion and $3 billion in capital expenditures for the full year 2026. Beyond 2026, spending will depend on revenue and growth expectations.
- CHIPS Act Benefits: TI received $555 million in direct funding proceeds from the U.S. CHIPS and Science Act in Q1 2026 (vs. $260 million in Q1 2025). The company expects to continue benefiting from the 35% investment tax credit and direct funding for its 300mm wafer fabs.
- Market Outlook: Management notes the overall analog and embedded semiconductor market recovery is continuing, with growth driven by industrial, automotive, and data center markets. Inventory levels are being managed to maintain competitive lead times.
- Risks: Key risks include global economic conditions, semiconductor cycle volatility, supply chain constraints, geopolitical tensions, and the successful integration of the Silicon Labs acquisition.
Investor Verification Checklist
- Acquisition Financing: Verify the final terms and funding structure for the $7.5 billion Silicon Labs acquisition, including any new debt issuance.
- Capex Trajectory: Monitor the execution of the planned $2–3 billion capex for 2026 and the transition from the elevated six-year cycle to a maintenance level.
- Margin Sustainability: Assess whether the improved gross and operating margins (58.0% and 37.5% respectively) are sustainable as factory loadings fluctuate with the semiconductor cycle.
- CHIPS Act Utilization: Track the receipt of remaining direct funding and the application of investment tax credits to ensure projected cash benefits materialize.
- Inventory Management: Review Days of Inventory (209 days in Q1 2026) to ensure it remains aligned with demand forecasts and does not signal obsolescence risks.